Last updated 2026-07-26
- Raised $71M Series D led by OurCrowd, Jun 2020
- Raised $27.8M Series C led by GEOC, Jan 2019
- Raised $15.8M Series B led by GEOC, Jul 2016
Total raised
$123.8M
Last: Undisclosed Round 2020-07
Stage
Mature
Founded
2010
Headcount
125
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences
About
Sight Diagnostics is a blood diagnostic company that combines machine vision and AI to improve health through fast, accurate, and convenient diagnostic testing. The company's technology, developed over a decade of research, represents innovations in blood sample preparation and optics, as well as advancements in chemistry, biology, physics, and computer science. Their products include the Parasight platform for malaria detection and Sight OLO, an analyzer that performs complete blood count (CBC) tests from a finger prick or venous sample, delivering lab-grade results in minutes. Sight OLO digitizes blood samples by capturing thousands of high-resolution images and analyzing them with proprietary algorithms. It has received FDA 510(k) clearance for use in moderately complex settings in the US and CE Mark for point-of-care use in Europe.
Funding history · 5 rounds · $123.8M total
2020-06
D Round
$71.0M
★ OurCrowd★ Longliv Ventures★ Koch Disruptive Technologies
2019-01
C Round
$27.8M
★ GEOC★ OurCrowd★ Steven Esrick★ Jack Nicklaus II★ Longliv Ventures★ New Alliance Capital
2016-07
B Round
$15.8M
★ GEOC★ Formed★ OurCrowd★ Qure Ventures★ New Alliance Capital
2014-03
A Round
$6.0M
★ OurCrowdMoshe YanaiEmery CapitalQure VenturesInnovation EndeavorsClal Biotechnology Industries (CBI)
2011-07
Seed
$3.2M
★ Moshe Yanai
Headcount over time
From 25 (2018-08) to 20 (2026-07) · -5 (-20%) · 24 points · source: Finder history + radar grounding
Q&A
- What is Sight Diagnostics' primary focus?
- Sight Diagnostics develops AI-driven blood diagnostic solutions for rapid and accurate testing, combining machine vision and AI to improve health through fast, accurate, and convenient diagnostic testing.
- What are Sight Diagnostics' key products?
- Sight Diagnostics' products include the Parasight platform for malaria detection and Sight OLO, an analyzer that performs complete blood count (CBC) tests from a finger prick or venous sample, delivering lab-grade results in minutes.
- What is the regulatory status of Sight OLO?
- Sight OLO has received FDA 510(k) clearance for use in moderately complex settings in the US and CE Mark for point-of-care use in Europe.
- When did Sight Diagnostics receive Health Canada approval for Sight OLO?
- In January 2022, Sight Diagnostics and Inter Medico announced the Health Canada approval of Sight OLO for Point-of-Care Testing.
- What was Sight Diagnostics' most recent equity funding round?
- Sight Diagnostics raised a $71 million D Round in August 2020, with lead investors including Koch Disruptive Technologies.
- What was the most recent financial event for Sight Diagnostics?
- In November 2023, Sight Diagnostics secured Debt Financing.
- How many employees does Sight Diagnostics currently have?
- Sight Diagnostics currently has 20 employees, which falls into the 51-200 employee bucket.
- Has Sight Diagnostics expanded its operations to the Gulf Region?
- Yes, in December 2020, Sight Diagnostics expanded to the Gulf Region through a distribution partnership with Phoenix Capital.
- What was a significant deployment of Sight OLO in 2021?
- In March 2021, Israel's Sight Diagnostics' Sight OLO was deployed at Oxford University's John Radcliffe Hospital.
Team · 2
Yossi Pollak
Founder · Co-Founder & CEO
Daniel Levner
Founder · Co-Founder
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision SupportDigital Medical DiagnosticsMedical DevicesDiagnostics Devices
Technologies
Artificial IntelligenceComputer VisionMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersLaboratories
Business model
B2B
Highlights
1 Patents
Tags
blood-testmedical-devicesdiagnosticsreal-timecomputer-visioninfectious-diseasehematologybioinformaticsartificial-intelligencemedical-technologiespediatricsoncologydata-analyticsinfectionhospitalsdigital-healthcaremachine-learningdetectiondoctorsimage-processingclinicslaboratories
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | sightdx.com/en |
|---|---|
| linkedin.com/company/5066984 | |
| facebook.com/sightdx | |
| YouTube | youtube.com/channel/UCHlPq_nv5YWet6nyvNDKRWw |
Identifiers & details
| Legal name | S.D. Sight Diagnostics Ltd. |
|---|---|
| Founded | 2010-9 |
| Employees (exact) | 125 |
Radar intelligence
Patents
| EPO | 23 |
|---|
Web history (Wayback)
| Domain | sightdx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 14 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514496280 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2010-09-13 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 2 — shares_capital (1), people (1) |
| Registered address | דרך בגין 23 תל אביב - יפו |
Recent registry events
| Date | Event |
|---|---|
| 2026-05-10 | העברת מניות |
| 2026-04-06 | עדכון דירקטורים-הסרת דירקטור |